AstraZeneca Fights Generic Diabetes Drug Launch
AstraZeneca on Thursday asked a London court to block pharmaceutical company Glenmark from launching a generic version of the drug giant's $1 billion Type 2 diabetes treatment Forxiga, ahead of a...To view the full article, register now.
Already a subscriber? Click here to view full article